Ian Parney
Program Director, Neurosurgical Oncology Fellowship · Mayo Clinic College of Medicine and Science
Credentials: · · · ·
History
PresentNeurosurgical Oncology Fellowship · Mayo Clinic College of Medicine and Science
- Present
Neurosurgical Oncology Fellowship · Mayo Clinic College of Medicine and Science
- 2002–2009
- 1989–1993
Research
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Nature Medicine · 2007 · 1,152 citations
The Lancet Oncology · 2017 · 969 citations
Review · Neuro-Oncology · 2018 · 581 citations
38 papers
- CG
29 papers
24 papers · 4 as a fellow
21 papers · 11 as a fellow
19 papers · 16 as a resident
19 papers
- JB
18 papers
15 papers
Grants
- 2021–2027
Center of Innovation for Brain Tumor Therapeutics
National Cancer Institute · U19
Project lead · $1.4M · Mayo Clinic Rochester
Clinical trials
- 2018–2028
Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
Principal investigator · Active not recruiting · Phase 2
Mayo Clinic
- 2013–2021
Vaccine Therapy in Treating Patients With Recurrent Glioblastoma
Principal investigator · Completed · Early phase 1
Mayo Clinic
- 2013–2016
Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Principal investigator · Completed · Early phase 1
Mayo Clinic
- 2013–2023
Study chair · Terminated · Phase 2
Alliance for Clinical Trials in Oncology